Renaissance of Radiotherapy in Intestinal Lymphoma? 10‐Year Efficacy and Tolerance in Multimodal Treatment of 134 Patients: Follow‐up of Two German Multicenter Consecutive Prospective Phase II Trials

PURPOSE: This article reports on the long‐term impact of radiotherapy adapted to stage, histology, and previous resection in a large cohort of patients with intestinal lymphoma (iL) treated with definitive or adjuvant curative‐intent radiation therapy (RT) ± chemotherapy (CHOP, MCP, or COP). PATIENT...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinartz, Gabriele, Molavi Tabrizi, Caroline, Liersch, Ruediger, Ullerich, Hansjoerg, Hering, Dominik, Willborn, Kay, Schultze, Juergen, Micke, Oliver, Ruebe, Christian, Fischbach, Wolfgang, Bentz, Martin, Daum, Severin, Pott, Christiane, Tiemann, Markus, Moeller, Peter, Neubauer, Andreas, Wilhelm, Martin, Lenz, Georg, Berdel, Wolfgang E., Willich, Normann, Eich, Hans T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Hematologic Malignancies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216456/
https://www.ncbi.nlm.nih.gov/pubmed/32219909
http://dx.doi.org/10.1634/theoncologist.2019-0783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216456/
https://www.ncbi.nlm.nih.gov/pubmed/32219909
http://dx.doi.org/10.1634/theoncologist.2019-0783

Ejemplares similares